64.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRSP Giù?
Forum
Previsione
Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Lowered to $78.00 at Bank of America - MarketBeat
CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
What drives CRISPR Therapeutics AG stock priceExceptional stock performance - PrintWeekIndia
Private Advisor Group LLC Buys 23,382 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Sees Large Volume IncreaseStill a Buy? - MarketBeat
CRISPR Therapeutics AG Stock Analysis and ForecastExplosive portfolio gains - Autocar Professional
Is CRISPR Therapeutics AG a good long term investmentFree Buy/Sell Signal Notifications - Autocar Professional
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
[Latest] Global CRISPR Gene Editing Market Size/Share Worth - GlobeNewswire
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
CRISPR Therapeutics Bets On Gene Editing’s Future With Casgevy - Finimize
CRISPR Therapeutics (CRSP) Surges 71% Last Quarter With Inclusion In Russell Indices - simplywall.st
Crispr Therapeutics: Shares Are SoaringThis Could Be The Start Of Something Big (CRSP) - Seeking Alpha
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN
What analysts say about CRISPR Therapeutics AG stockTremendous gains - jammulinksnews.com
Research Analysts Set Expectations for CRSP Q2 Earnings - MarketBeat
Crispr Therapeutics price target lowered to $78 from $79 at BofA - TipRanks
CRISPR Therapeutics' Stock Surge: A Glimpse into the Future of Gene-Editing Investment - AInvest
CRISPR Therapeutics Rises Amid Gene Editing Breakthroughs - StocksToTrade
CRISPR Stock (CRSP) Continues to Sizzle on Insider Deal - TipRanks
CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 1-Year High Following Insider Buying Activity - MarketBeat
3 Monster Stocks in the Making to Buy Right Now - The Motley Fool
CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading - MSN
Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Average Price Target from Analysts - MarketBeat
Crispr Therapeutics AG Stock Soars Amid Insider Confidence - TipRanks
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):